BIOM3
ONconsolidatedBIOMM S.A.
CNPJ 04752991000110
—
Ratios
Q3 25 → Q2 26Share capital from the FRE dated 2026-12-31. The FRE is annual — buybacks and issuances after that date are not reflected here.
computed — The CVM does not publish Q4 on its own — the annual filing carries the full year. This figure is the year minus the first nine months.
Ratios by year
| Year | Revenue | Net income | Gross margin | Net margin | ROE | ROA | Turnover | Year-end price | P/E | DY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 269.30m | -6.69m | 31.6% | -2.5% | -2.1% | -1.3% | 0.51 | 7.22 | — | — |
| 2024 | 142.91m | -77.24m | 12.5% | -54.1% | -29.4% | -16.6% | 0.31 | 10.66 | — | — |
| 2023 | 118.19m | -81.14m | 19.7% | -68.7% | -66.0% | -23.5% | 0.34 | 5.78 | — | — |
| 2022 | 104.95m | -92.56m | 15.2% | -88.2% | -58.2% | -22.9% | 0.26 | 6.79 | — | — |
| 2021 | 107.09m | -80.26m | 25.2% | -75.0% | -71.9% | -21.7% | 0.29 | 12.98 | — | — |
| 2020 | 58.67m | -70.77m | 23.8% | -120.6% | -37.0% | -16.3% | 0.13 | 16.21 | — | — |
| 2019 | 8.94m | -55.81m | 5.8% | -624.0% | -36.4% | -14.4% | 0.02 | 12.40 | — | — |
| 2018 | 1.57m | -42.56m | 15.6% | -2,717.9% | -40.1% | -13.9% | 0.01 | 8.17 | — | — |
| 2017 | 103.0k | -38.13m | 35.0% | -37,017.5% | -64.3% | -14.5% | 0.00 | 9.50 | — | — |
| 2016 | 0.00 | -45.61m | — | — | -69.2% | -19.2% | — | 6.45 | — | — |
| 2015 | 0.00 | 8.28m | — | — | 7.2% | 3.6% | — | 5.60 | 20.74 | — |
| 2014 | 0.00 | -12.71m | — | — | -11.9% | -7.1% | — | 8.50 | — | — |
| 2013 | 0.00 | -10.06m | — | — | -9.2% | -7.3% | — | 9.99 | — | — |
| 2012 | 0.00 | -14.14m | — | — | — | -169.8% | — | 4.55 | — | — |
| 2011 | 0.00 | -4.68m | — | — | — | -37.3% | — | 3.49 | — | — |
| 2010 | 877.0k | -4.27m | 50.3% | -487.2% | — | -87.1% | 0.18 | 2.56 | — | — |
From each fiscal year's DFP, with the close of the fiscal year-end month alongside. Yearly P/E and DY use the fiscal year-end close against that year's EPS and payouts — both already per share. An empty cell carries its reason in the tooltip: a loss, EPS out of scale, lot-of-a-thousand quoting, a split in the way. Yearly P/B is left out: it would need that year's share count, and the registration filing stores the latest approval's count under the reference date.
Quarterly results
| Period | Revenue | Operating | Net income | Net margin |
|---|---|---|---|---|
| Q2 26 | 89.43m | 8.94m | 1.85m | 2.1% |
| Q1 26 | 92.46m | 16.85m | 19.01m | 20.6% |
| Q4 25 | 166.77m | 31.72m | 29.38m | 17.6% |
| Q3 25 | 35.76m | -11.29m | -10.60m | -29.6% |
| Q2 25 | 27.17m | -12.84m | -13.74m | -50.6% |
| Q1 25 | 39.59m | -12.84m | -11.74m | -29.6% |
| Q4 24 | 40.00m | -24.27m | -25.59m | -64.0% |
| Q3 24 | 32.26m | -18.89m | -16.28m | -50.5% |
| Q2 24 | 32.08m | -20.52m | -18.28m | -57.0% |
| Q1 24 | 38.56m | -17.54m | -17.08m | -44.3% |
| Q4 23 | 20.00m | -18.74m | -21.06m | -105.3% |
| Q3 23 | 33.13m | -19.90m | -21.93m | -66.2% |
Balance sheet
| Period | Total assets | Equity | Assets / Equity | Current ratio |
|---|---|---|---|---|
| Q2 26 | 614.93m | 325.20m | 1.89 | 1.55 |
| Q1 26 | 573.45m | 323.36m | 1.77 | 1.77 |
| Q4 25 | 524.23m | 313.51m | 1.67 | 2.23 |
| Q3 25 | 485.03m | 284.10m | 1.71 | 2.45 |
| Q2 25 | 417.97m | 238.01m | 1.76 | 2.64 |
| Q1 25 | 448.16m | 250.99m | 1.79 | 2.64 |
| Q4 24 | 465.90m | 262.78m | 1.77 | 2.72 |
| Q3 24 | 486.44m | 288.37m | 1.69 | 3.36 |
| Q2 24 | 504.14m | 304.66m | 1.65 | 3.97 |
| Q1 24 | 541.44m | 322.88m | 1.68 | 3.77 |
| Q4 23 | 344.70m | 122.94m | 2.80 | 1.52 |
| Q3 23 | 339.41m | 99.01m | 3.43 | 1.40 |
A balance sheet is a snapshot, not a window: there is no “computed Q4” here — December's figure is what the annual filing published.
What the company filed
| Filing | Period | Filed on | Days after close | Document |
|---|---|---|---|---|
| ITRT2 | 2026-06-30 | 2026-08-14 | 45 | CVM ↗ |
| ITRT1 | 2026-03-31 | 2026-05-15 | 45 | CVM ↗ |
| DFPanual | 2025-12-31 | 2026-03-25 | 84 | CVM ↗ |
| ITRT3 | 2025-09-30 | 2025-11-14 | 45 | CVM ↗ |
| ITRT2 | 2025-06-30 | 2025-08-14 | 45 | CVM ↗ |
| ITRT1 | 2025-03-31 | 2025-05-15 | 45 | CVM ↗ |
| DFPanual | 2024-12-31 | 2025-03-28 | 87 | CVM ↗ |
| ITRT3 | 2024-09-30 | 2024-11-13 | 44 | CVM ↗ |
| ITRT2 | 2024-06-30 | 2024-08-13 | 44 | CVM ↗ |
| ITRT1 | 2024-03-31 | 2024-05-15 | 45 | CVM ↗ |
| DFPanual | 2023-12-31 | 2024-03-27 | 87 | CVM ↗ |
| ITRT3 | 2023-09-30 | 2023-11-13 | 44 | CVM ↗ |
| ITRT2 | 2023-06-30 | 2023-08-10 | 41 | CVM ↗ |
| ITRT1 | 2023-03-31 | 2023-05-11 | 41 | CVM ↗ |
| DFPanual | 2022-12-31 | 2023-03-23 | 82 | CVM ↗ |
| ITRT3 | 2022-09-30 | 2022-11-10 | 41 | CVM ↗ |
When the next one is due
This is measured habit, not company guidance: the CVM publishes no forward calendar as open data. The estimate applies this company's historical median to the next period.